SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001437749-14-020330
Filing Date
2014-11-12
Accepted
2014-11-12 06:06:41
Documents
11
Period of Report
2014-09-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q insy20140930_10q.htm 10-Q 991786
2 EXHIBIT 10.1 ex10-1.htm EX-10 40321
3 EXHIBIT 31.1 ex31-1.htm EX-31 12422
4 EXHIBIT 31.2 ex31-2.htm EX-31 12543
5 EXHIBIT 32 ex32.htm EX-32 7539
  Complete submission text file 0001437749-14-020330.txt   5818748

Data Files

Seq Description Document Type Size
6 EXHIBIT 101.INS insy-20140930.xml EX-101.INS 985078
7 EXHIBIT 101.SCH insy-20140930.xsd EX-101.SCH 37417
8 EXHIBIT 101.CAL insy-20140930_cal.xml EX-101.CAL 33764
9 EXHIBIT 101.DEF insy-20140930_def.xml EX-101.DEF 192729
10 EXHIBIT 101.LAB insy-20140930_lab.xml EX-101.LAB 258228
11 EXHIBIT 101.PRE insy-20140930_pre.xml EX-101.PRE 191121
Mailing Address 10220 SOUTH 51ST STREET SUITE 2 PHOENIX AZ 85044
Business Address 10220 SOUTH 51ST STREET SUITE 2 PHOENIX AZ 85044 602-910-2617
Insys Therapeutics, Inc. (Filer) CIK: 0001516479 (see all company filings)

IRS No.: 510327886 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-35902 | Film No.: 141210755
SIC: 2834 Pharmaceutical Preparations